These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 185448

  • 1. [Use of miskleron in ischemic heart disease with differing types of hyperlipoproteinemias].
    Krivoruchenko IV, Nikul'cheva NG.
    Kardiologiia; 1976 Jul; 16(7):71-5. PubMed ID: 185448
    [Abstract] [Full Text] [Related]

  • 2. A double-blind comparison of the hypolipidemic and hypouricemic action of halofenate and clofibrate in patients with hyperlipoproteinemia (types III, IV and V).
    Neuman J, de Neuman MP, Talmasky S, Pesce R, Valero E, Martiarena JL.
    J Cardiovasc Surg (Torino); 1973 Jul; Spec No():532-7. PubMed ID: 4377715
    [No Abstract] [Full Text] [Related]

  • 3. [Clofibrate treatment of diabetics with hyperproteinemias (author's transl)].
    Jung W, Kremer GJ, Müller D.
    MMW Munch Med Wochenschr; 1975 Oct 31; 117(44):1783-6. PubMed ID: 171564
    [Abstract] [Full Text] [Related]

  • 4. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
    Gustafson A.
    Postgrad Med J; 1975 Oct 31; 51(8):suppl 66-71. PubMed ID: 215983
    [No Abstract] [Full Text] [Related]

  • 5. [Familial hyperlipoproteinemia type III].
    Patsch JR, Patsch W, Sailer S, Braunsteiner H.
    Dtsch Med Wochenschr; 1976 Oct 29; 101(44):1612-9. PubMed ID: 185039
    [No Abstract] [Full Text] [Related]

  • 6. [Clofibrate action on the lipoprotein composition in primary type IV and type V hyperlipoproteinemia].
    Weisweiler P, Schwandt P.
    Verh Dtsch Ges Inn Med; 1976 Oct 29; 83():398-401. PubMed ID: 206058
    [No Abstract] [Full Text] [Related]

  • 7. [Treatment of primary hyperlipoproteinemias. Comparison of N 041 with clofibrate].
    Gaertner U, Johannes KJ.
    MMW Munch Med Wochenschr; 1976 Sep 03; 118(36):1127-30. PubMed ID: 184377
    [Abstract] [Full Text] [Related]

  • 8. Secholex, Clofibrate and taurine in hyperlipidaemia.
    Howard AN, Evans RJ.
    Atherosclerosis; 1974 Sep 03; 20(1):105-16. PubMed ID: 4376405
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment of primary hyperlipoproteinemias of type IIB and IV with butylbiguanide and clofibrate (author's transl)].
    Koschinsky T, Gries FA, Schwandt P, Weisweiler P, Hansen W, Nijssen J, Beckmann R.
    MMW Munch Med Wochenschr; 1977 May 20; 119(20):701-4. PubMed ID: 195201
    [Abstract] [Full Text] [Related]

  • 10. [Comparative studies on the cholesterol and triglyceride-lowering effect of alpha-methylthyroxine (Skleronorm) and clofibrate (Regelan) in hyperlipoproteinemias of type IIa/b and IV].
    Jantke J, Schwartzkopff W, Zschiedrich M.
    Verh Dtsch Ges Inn Med; 1977 May 20; 83():392-5. PubMed ID: 206057
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Does hypolipidemic therapy prevent coronary heart disease?
    Rifkind BM, Levy RI.
    Cardiovasc Clin; 1974 May 20; 6(2):1-8. PubMed ID: 4374303
    [No Abstract] [Full Text] [Related]

  • 13. Clofibrate in type II hyperlipoproteinemia.
    Ditzel J, Bang HO.
    Acta Med Scand; 1976 May 20; 200(1-2):55-58. PubMed ID: 183462
    [Abstract] [Full Text] [Related]

  • 14. Hyperlipoproteinemia. Some basic concepts on diagnosis and management.
    Levy RI.
    JAMA; 1973 Nov 05; 226(6):648-9. PubMed ID: 4356846
    [No Abstract] [Full Text] [Related]

  • 15. Gemfibrozil treatment: a comparison with clofibrate.
    Howard AN, Ghosh P.
    Proc R Soc Med; 1976 Nov 05; 69 Suppl 2(Suppl 2):88-9. PubMed ID: 190609
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Treating lipid disorders.
    Manninen V, Mälkönen M, Tuomilehto J.
    Am Heart J; 1979 May 05; 97(5):674-6. PubMed ID: 219673
    [No Abstract] [Full Text] [Related]

  • 19. Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy.
    Falko JM, Witztum JL, Schonfeld G, Weidman SW, Kolar JB.
    Am J Med; 1979 Feb 05; 66(2):303-10. PubMed ID: 218451
    [No Abstract] [Full Text] [Related]

  • 20. Bile acid metabolism in hyperlipoproteinaemia.
    Hellström K, Einarsson K.
    Clin Gastroenterol; 1977 Jan 05; 6(1):103-28. PubMed ID: 196796
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.